A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT05421078

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05421078
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05421078. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-27 (actual); primary completion 2023-03-24 (actual). Results posted on 2024-09-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
Condition
Dyslipidemia
Condition
Hypercholesterolemia
Condition
High Cholesterol
Intervention (Drug)
Obicetrapib
Intervention (Drug)
Placebo
Lead sponsor
NewAmsterdam Pharma (class: industry)

Record details

Record id
cardio:ct-nct05421078
Content hash
2ed989c1c959a055d87fa6eedf55dedc61cefc2e39313b86e6d2252944a25608